Abstract
Abundant mycolic acids are the hallmark of the mycobacterial cell wall. The biosynthesis of mycolic acids fulfilled by type I (Fas-I) and type II (Fas-II) synthase systems necessitates long chain fatty acids as the raw material. Fas-I is responsible for de novo fatty acid synthesis to form fatty acids 16-24 carbons in length and then elongated by the monofunctional enzymes of Fas-II to form long chain fatty acids, and further to form mycolic acids. Mutation of monofunctional enzymes can confer mycobacterial drug resistance. The key monofunctional enzymes of this system might represent new drug target candidates for antituberculosis drug development.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.